Stocks and Investing Stocks and Investing
Wed, January 3, 2024

David Amsellem Upgraded (TEVA) to Hold and Increased Target to $12 on, Jan 3rd, 2024


Published on 2024-10-28 08:10:18 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Increased Target from $8 to $12 on, Jan 3rd, 2024.

David has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $13 on, Monday, December 18th, 2023
  • Ashwani Verma of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $13 on, Monday, November 27th, 2023
  • Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $13 on, Friday, September 8th, 2023
Contributing Sources